{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-024492","form_type":"8-K","ticker":"WAT","cik":"0001000697","company_name":"WATERS CORP /DE/","filed_at":"2026-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.365418+00:00","generated_at":"2026-05-16T07:20:02.993868+00:00","sec_items":["5.07","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Waters shareholders approve BD Biosciences combination; close expected Feb 9, 2026","bullets":["Approximately 99% of shares present at special meeting voted to approve share issuance for BD Biosciences deal.","Transaction expected to close on February 9, 2026, subject to remaining customary conditions.","IRS private letter ruling on tax consequences received; all required regulatory approvals secured.","Waters Q4 2025 earnings release and conference call rescheduled to February 9, 2026, in conjunction with close."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-024492","json":"https://secwatch.observer/filing/0001193125-26-024492.json","markdown":"https://secwatch.observer/filing/0001193125-26-024492.md","text":"https://secwatch.observer/filing/0001193125-26-024492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/0001193125-26-024492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000697/000119312526024492/d60099d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:20:02.993868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}